Exploring the Mechanism of Kai‐Xin‐San to Improve Cognitive Deficits in AD Rats Induced by D‐Gal and Aβ 25–35 Based on Multi‐Omics and Network Analysis
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Lifen Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovation Team of Processing Technique of Traditional Chinese Medicine, Science and Technology projects of Jiangxi Market Supervision Bureau.
Abstract (Originalsprache)
Alzheimer's disease ( AD ) is a common neurodegenerative disease for which there are no effective drugs. Kai‐Xin‐San (KXS), with definite curative effects, is widely used for the prevention and treatment of AD in China. But its mechanism is not yet fully understood. Based on our established rat model and previous pharmacodynamics study, Multi‐omics (metabolomics, proteomics) and network analysis were integrated to explore the holistic mechanism of anti‐ AD effects of KXS. The key pathways were validated with western blot and ELISA methods. Morris water maze and Nissl staining showed that KXS could ameliorate cognitive deficits and pathological morphology of the hippocampus in AD rats. A total of nine metabolites were identified, which were related to pyrimidine metabolism, riboflavin metabolism, tyrosine metabolism, tryptophan metabolism, and glycerophospholipid metabolism. Proteomics results indicated that the improvement of cognitive deficits by KXS was closely related to the regulation of oxidative phosphorylation in mitochondria. Western blotting results showed that KXS significantly inhibited the expression of Mt‐nd2 and Ndufb6 in AD rats. Integrated analysis indicated that the anti‐ AD targets of KXS were interrelated and KXS could exert its anti‐ AD effect by reducing oxidative stress, neurotoxicity, and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang, China.
- Nanchang Key Laboratory for Quality and Safety Risk Assessment of Health Food and Its Contact Materials, Nanchang Inspection and Testing Center, Nanchang, China.
- Laboratory Animal Science and Technology Development Center, Jiangxi University of Chinese Medicine, Nanchang, China.
ORCID-Profile: Lifen Zhou
Förderung
- National Natural Science Foundation of China
- Innovation Team of Processing Technique of Traditional Chinese Medicine
- Science and Technology projects of Jiangxi Market Supervision Bureau
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Zhou, L., Zhang, M., Zheng, Q., Song, Y., Yan, Z., Wang, H., Xiong, Y., Chen, Y., Cai, Z., & Yuan, J. (2025). Exploring the Mechanism of Kai‐Xin‐San to Improve Cognitive Deficits in AD Rats Induced by D‐Gal and Aβ 25–35 Based on Multi‐Omics and Network Analysis. Biomedical Chromatography. https://doi.org/10.1002/bmc.70047
Vancouver
Zhou L, Zhang M, Zheng Q, Song Y, Yan Z, Wang H, et al. Exploring the Mechanism of Kai‐Xin‐San to Improve Cognitive Deficits in AD Rats Induced by D‐Gal and Aβ 25–35 Based on Multi‐Omics and Network Analysis. Biomedical Chromatography. 2025. doi:10.1002/bmc.70047
BibTeX
@article{Zhou2025,
author = {Zhou, Lifen and Zhang, Min and Zheng, Qin and Song, Yonggui and Yan, Zhihong and Wang, Huijuan and Xiong, Yongchang and Chen, Ying and Cai, Zhinan and Yuan, Jinbin},
title = {Exploring the Mechanism of Kai‐Xin‐San to Improve Cognitive Deficits in AD Rats Induced by D‐Gal and Aβ 25–35 Based on Multi‐Omics and Network Analysis},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70047}
}
EUVIMED